WallStreetZenWallStreetZen

NASDAQ: ABCL
Abcellera Biologics Inc Stock Ownership - Who owns Abcellera Biologics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Abcellera Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael R. HaydenDirector2026-08-2453,613$10.64
$570.44kBuy
John S. MontalbanoDirector2026-08-1810,000$11.03
$110.30kBuy
Andrew BoothCFO2026-08-1437,200$10.32
$383.90kBuy
Michael R. HaydenDirector2026-08-1246,387$10.37
$481.03kBuy
Andrew BoothChief Financial Officer2026-06-03250,000$0.19
$47.50kBuy
John S. MontalbanoDirector2026-05-1420,000$4.77
$95.40kBuy
Andrew BoothChief Financial Officer2026-02-2742,600$3.42
$145.69kBuy
Thermopylae Holdings Ltd10% Owner2026-02-2738,000$3.44
$130.72kBuy
Thermopylae Holdings Ltd10% Owner2026-02-26177,457$3.27
$580.28kBuy
John S. MontalbanoDirector2025-11-2650,000$3.57
$178.45kBuy

1 of 1

ABCL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABCL insiders and whales buy or sell their stock.

ABCL Shareholders

What type of owners hold Abcellera Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Carl L. G. Hansen18.59%56,984,009$725.41MInsider
Thermopylae Holdings Ltd18.31%56,134,097$714.59MInsider
John Hamer4.81%14,734,623$187.57MInsider
Michael R. Hayden0.96%2,933,284$37.34MInsider
Veronique Lecault0.80%2,458,666$31.30MInsider
Stephen Quake0.36%1,100,436$14.01MInsider
Ester Falconer0.29%875,000$11.14MInsider
Andrew Booth0.24%744,718$9.48MInsider
John S. Montalbano0.09%261,000$3.32MInsider
Andrew Lo0.03%86,938$1.11MInsider

1 of 3

ABCL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABCL0.04%44.49%Net BuyingNet Buying
XENE0.10%2.58%Net SellingNet Selling
CELC0.12%22.15%Net SellingNet Selling
IDYA0.11%7.88%Net BuyingNet Buying
TNGX0.13%49.41%Net SellingNet Buying
View Top Biotech Stocks

Abcellera Biologics Stock Ownership FAQ

Who owns Abcellera Biologics?

Abcellera Biologics (NASDAQ: ABCL) is owned by 0.04% institutional shareholders, 44.49% Abcellera Biologics insiders, and 55.47% retail investors. Carl L. G. Hansen is the largest individual Abcellera Biologics shareholder, owning 56.98M shares representing 18.59% of the company. Carl L. G. Hansen's Abcellera Biologics shares are currently valued at $719.71M.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.